The FDA recently approved Kalydeco, the first drug to address the underlying cause of cystic fibrosis for a small segment of the CF population. Meet an adult who is benefiting from this groundbreaking drug, and two children who are still in need of a lifesaving treatment for CF.
Advances being made in CF research have the potential to make dreams come true for people with CF that were impossible just decades ago. The CF Foundation asked some of the many people affected by this disease to share their dreams for the future. Caution: Contains sensitive and emotional dialogue from parents who have lost their children to CF. Visit http://www.cff.org to learn more.